Brief: Changmao Biochemical Engineering Sees Consol Net Profit Attributable In FY
20/02/2019 08:55
Feb 20 (Reuters) - Changmao Biochemical Engineering Co Ltd
0954.HK :
* LIKELY TO RECORD A CONSOLIDATED NET PROFIT ATTRIBUTABLE TO
EQUITY HOLDERS OF COMPANY FOR YEAR
* GROUP IS LIKELY TO RECORD A CONSOLIDATED NET PROFIT
ATTRIBUTABLE
FOR YEAR OF ABOUT RMB45 MILLION TO RMB 55 MILLION
* TO RECORD A CONSOLIDATED NET PROFIT ATTRIBUTABLE OF ABOUT
RMB45-55 MILLION FOR FY
* EXPECTED RESULT DUE TO INCREASE IN SELLING PRICE OF MAJOR
PRODUCTS
Source text for Eikon: ID:nHKS1t5fQh
Further company coverage: 0954.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Changmao Biochemical Engineering
See all newsBrief: Changmao Biochemical Engineering Says Dalian To Transfer Leased Assets For RMB50 Mln
Brief: Changmao Biochemical Engineering Says To Suspend Proposed Plan For IPO
Brief: Changmao Biochemical Engineering Sees Consolidated Net Loss Attributable For Year
Brief: Changmao Biochemical Engineering Approved To Apply For A New Project Bank Loan
Brief: Changmao Biochemical Engineering Sees FY Consol Net Profit Attributable Of RMB70 Mln-RMB90 Mln